Email alvin.chua@nus.edu.sg

Alvin is a Research Fellow at the Saw Swee Hock School of Public Health. His work focuses on antimicrobial resistance (AMR) and pandemic preparedness.

He has contributed to several studies on AMR and health systems, focusing on analysing national action plans on AMR in Southeast Asia to identify and develop strategies for improvement.

As a trained antimicrobial stewardship pharmacist, Alvin collaborates with Cambodian stakeholders, including hospitals, NGOs, the WHO, and Cambodia’s Ministry of Health, to establish stewardship programmes and research antimicrobial use. Recently, he partnered with these stakeholders and the International Centre for Antimicrobial Resistance Solutions (ICARS) to optimise antimicrobial use in Cambodian hospitals.

Beyond AMR, Alvin has studied health system resilience during COVID-19 as part of a scientific research group, providing valuable insights on effective pandemic responses to the Independent Panel for Pandemic Preparedness and Response.

Currently, he continues this work with the Asia Centre for Health Security (ACHS) and as a member of the scientific coordination group for the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation (PRIME) Commission.

• NUS Saw Swee Hock School of Public Health

• Antimicrobial resistance
• Antimicrobial stewardship
• Pandemic prevention, preparedness, and response

• PhD, National University of Singapore, 2024
• Master of Science (Infectious Diseases), London School of Hygiene and Tropical Medicine, 2018
• Bachelor of Science with Honours (Pharmacy), National University of Singapore, 2011

• Research Associate, Saw Swee Hock School of Public Health (2019 to 2025)
• Senior Clinical Pharmacist, Singapore General Hospital (2013 to 2019)
• Pharmacist, Singapore General Hospital (2011 to 2013)

• Chua AQ, Verma M, Azupardo K, Lota MM, Hsu LY, Legido-Quigley H. A qualitative study on the policy process and development of the national action plan on antimicrobial resistance in Singapore. Antibiotics (Basel). 2023;12(8):1322. doi: 10.3390/antibiotics12081322.
• Chua AQ, Verma M, Villanueva SYA, Roxas E, Hsu LY, Legido-Quigley H. A qualitative study on the implementation of the national action plan on antimicrobial resistance in Singapore. Antibiotics (Basel). 2023;12(8):1258. doi: 10.3390/antibiotics12081258.
• Lota MMM*, Chua AQ*, Azupardo K, Lumangaya C, Reyes KAV, Villanueva SYAM, Legido-Quigley H, Roxas EA. a qualitative study on the design and implementation of the national action plan on antimicrobial resistance in the Philippines. Antibiotics (Basel). 2022 Jun 17;11(6):820. doi: 10.3390/antibiotics11060820. *Authors contributed equally to this work.
• Chua AQ, Knawy BA, Grant B, Legido-Quigley H, Lee W-C, Leung GM, Looi M-K, Maurer-Stroh S. How the lessons of previous epidemics helped successful countries fight COVID-19. BMJ 2021;372:n486. doi: 10.1136/bmj.n486
• Chua AQ, Verma M, Hsu LY, Legido-Quigley H. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach. The Lancet Regional Health – Western Pacific. 2021;7(100084). doi: 10.1016/j.lanwpc.2020.100084
• Chua AQ, Tan MMJ, Verma M, Han EKL, Hsu LY, Cook AR, Teo YY, Lee VJ, Legido-Quigley H. Health system resilience in managing the COVID-19 pandemic: lessons from Singapore. BMJ Global Health. 2020;5(9). doi: 10.1136/bmjgh-2020-003317
• Singh SR*, Chua AQ*, Tan ST, Tam CC, Hsu LY, Legido-Quigley H. Combating Antimicrobial Resistance in Singapore: A qualitative study exploring the policy context, challenges, facilitators, and proposed strategies. Antibiotics (Basel). 2019 Oct 29;8(4). doi: 10.3390/antibiotics8040201. *Authors contributed equally to this work.
• Chua AQ, Kwa AL, Tan TY, Legido-Quigley H, Hsu LY. Ten-year narrative review on antimicrobial resistance in Singapore. Singapore Med J. 2019;60(8):387-396. doi: 10.11622/smedj.2019088
• Chua AQ, Tang SSL, Lee LW, Yii DYC, Kong ST, Lee W, Kwa AL, Lie D. Psychosocial determinants of physician acceptance toward an antimicrobial stewardship program and its computerized decision support system in an acute care tertiary hospital. J Am Coll Clin Pharm. 2018;1–8. doi: 10.1002/jac5.1028